Stay updated on Rituximab in Eosinophilic Granulomatosis Clinical Trial
Sign up to get notified when there's something new on the Rituximab in Eosinophilic Granulomatosis Clinical Trial page.

Latest updates to the Rituximab in Eosinophilic Granulomatosis Clinical Trial page
- CheckyesterdayChange DetectedAdded a Locations section for Paris (Paris, France, 75014) with site URC-CIC Paris Descartes Necker Cochin, and a new Study Results note about voluntary publications; removed the previous PubMed-derived Paris location and older update entries.SummaryDifference0.6%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedFooter shows a new Revision: v3.3.3 and removes HHS Vulnerability Disclosure and Revision: v3.3.2. These are minor maintenance changes that do not alter study details or eligibility information.SummaryDifference0.1%

- Check51 days agoChange DetectedFooter now displays Revision: v3.3.2, replacing the prior Revision: v3.3.1. This change is limited to a version label in the site footer and does not affect the study details, eligibility criteria, outcomes, or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check58 days agoChange DetectedAdded a note that PubMed publications are auto-filled and may not relate to the study. Updated the revision to v3.3.1.SummaryDifference0.1%

- Check66 days agoChange DetectedThe funding-lapse notice about updates and operating status has been removed from the page.SummaryDifference0.4%

- Check80 days agoChange DetectedNo substantive content changes to the study details; any observed differences are UI/layout adjustments that do not affect the page's purpose. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Rituximab in Eosinophilic Granulomatosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rituximab in Eosinophilic Granulomatosis Clinical Trial page.